Table 4: Specific reasons for modification

Variable Frequency (%)
Toxicity

Lipodystrophy

Peripheral neuropathy

Anaemia

Hyper-pigmentation

Rashes

CNS Side effects

Dyslipidemia

Renal Failure

Lactic Acidosis

Hepatotoxicity

Convulsive disorder

Co-morbid conditions

Tuberculosis

Pregnancy

Hepatitis B co-infection

Other

New guidelines

Lack of stock

Regimen simplification


422 (62.1)

108 (15.9)

60 (8.8)

22 (3.2)

20 (2.9)

14 (2.1)

12 (1.8)

12 (1.8)

4 (0.6)

4 (0.6)

2 (0.3)



52 (54.2)

62 (43.7)

2 (2.1)



82 (72.0)

28 (24.6)

4 (3.5)